Full-Time

Director – Vaccine Immunologist

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$161.6k - $269.4kAnnually

+ Bonus

Senior, Expert

No H1B Sponsorship

New City, NY, USA

Relocation support available.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • PhD in Immunology or related field
  • 10 -15 years of post-graduate experience (preferably in industry)
  • Strong background in Immunology
  • Immunoassay development experience
  • Strong written and verbal communication skills
  • People Management Experience
Responsibilities
  • Sets objectives for and manages multiple immunoassay development projects.
  • Collaborate as necessary with the appropriate leaders/scientists within Vaccine Research and Development to drive strategy for evaluation of vaccine-induced immune responses.
  • Interact with intra- and interdepartmental personnel in scientific discussions while advocating the appropriate clinical assays to address the scientific questions. The incumbent may also to lead or support external collaborations and/or technology transfers.
  • Immunology subject matter expert throughout assay lifecycle, including immunoassay qualification and/or validation.
  • Author publications relevant to the work being performed
  • Manage a diverse team of scientists at various levels
  • Write and review reports, technical documents and presentations to support assay development, qualification, validation and transfer.
  • Supervises laboratory staff including Managers.
  • Keep abreast of new scientific/ technology development by participating in scientific meetings/ seminars and through regular scientific review; in-house new technology/approaches as appropriate.
  • Quality: Ensure that Pfizer's values are reflected on a continuous basis in day-to-day job functions.

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?